Precipio Announces First US Government Customer for ICE COLD-PCR™ Mutation Enrichment Technology NEW HAVEN, Conn., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that it has been approved by the United States Department of...